Mechanism of pomegranate ellagic polyphenols reducing insulin resistance on gestational diabetes mellitus rats.
CONCLUSIONS: In conclusion, we have demonstrated that PEP may be a candidate drug for the treatment of GDM and guide the clinical therapy.
PMID: 31632524 [PubMed]
Source: American Journal of Translational Research - Category: Research Tags: Am J Transl Res Source Type: research
More News: Diabetes | Diabetes Mellitus | Diabetes Type 2 | Endocrinology | Insulin | Pancreas | Pomegranates | Pregnancy | Research | Study